JP2013515742A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2013515742A5 JP2013515742A5 JP2012546222A JP2012546222A JP2013515742A5 JP 2013515742 A5 JP2013515742 A5 JP 2013515742A5 JP 2012546222 A JP2012546222 A JP 2012546222A JP 2012546222 A JP2012546222 A JP 2012546222A JP 2013515742 A5 JP2013515742 A5 JP 2013515742A5
- Authority
- JP
- Japan
- Prior art keywords
- formulation
- terbinafine
- preparation
- short
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 12
- 238000009472 formulation Methods 0.000 claims 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 5
- DOMXUEMWDBAQBQ-WEVVVXLNSA-N terbinafine Chemical compound C1=CC=C2C(CN(C\C=C\C#CC(C)(C)C)C)=CC=CC2=C1 DOMXUEMWDBAQBQ-WEVVVXLNSA-N 0.000 claims 4
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims 3
- 150000001261 hydroxy acids Chemical class 0.000 claims 3
- 150000003839 salts Chemical class 0.000 claims 3
- 229960002722 terbinafine Drugs 0.000 claims 3
- 239000002888 zwitterionic surfactant Substances 0.000 claims 3
- 208000010195 Onychomycosis Diseases 0.000 claims 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims 2
- JBTWLSYIZRCDFO-UHFFFAOYSA-N ethyl methyl carbonate Chemical compound CCOC(=O)OC JBTWLSYIZRCDFO-UHFFFAOYSA-N 0.000 claims 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims 2
- 239000002562 thickening agent Substances 0.000 claims 2
- 201000005882 tinea unguium Diseases 0.000 claims 2
- 230000000699 topical effect Effects 0.000 claims 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 1
- 229940047648 cocoamphodiacetate Drugs 0.000 claims 1
- 229940047642 disodium cocoamphodiacetate Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 1
- 235000014655 lactic acid Nutrition 0.000 claims 1
- 239000004310 lactic acid Substances 0.000 claims 1
- 150000004666 short chain fatty acids Chemical class 0.000 claims 1
- 235000021391 short chain fatty acids Nutrition 0.000 claims 1
- 229960000699 terbinafine hydrochloride Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US28996209P | 2009-12-23 | 2009-12-23 | |
| US28996709P | 2009-12-23 | 2009-12-23 | |
| US61/289,967 | 2009-12-23 | ||
| US61/289,962 | 2009-12-23 | ||
| PCT/US2010/061940 WO2011079234A2 (en) | 2009-12-23 | 2010-12-22 | Highly permeating terbinafine formulation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2013515742A JP2013515742A (ja) | 2013-05-09 |
| JP2013515742A5 true JP2013515742A5 (enExample) | 2014-02-13 |
| JP5829217B2 JP5829217B2 (ja) | 2015-12-09 |
Family
ID=43770418
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012546222A Expired - Fee Related JP5829217B2 (ja) | 2009-12-23 | 2010-12-22 | 高浸透性テルビナフィン製剤 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9084754B2 (enExample) |
| EP (1) | EP2544659A2 (enExample) |
| JP (1) | JP5829217B2 (enExample) |
| CN (1) | CN102770123A (enExample) |
| AU (1) | AU2010336441B2 (enExample) |
| CA (1) | CA2785643A1 (enExample) |
| WO (1) | WO2011079234A2 (enExample) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2012215383B2 (en) | 2011-02-11 | 2016-06-09 | Moberg Pharma Ab | Novel antifungal composition |
| CN104105472A (zh) * | 2011-12-20 | 2014-10-15 | 维奥姆生物科学有限公司 | 用于治疗真菌感染的局部油组合物 |
| EP2664327A1 (en) | 2012-05-14 | 2013-11-20 | Almirall S.A. | Topical pharmaceutical compositions comprising terbinafide and urea |
| NL2009669C2 (en) * | 2012-10-19 | 2014-04-23 | Dutch Renewable Energy B V | Enhanced nail penetrating composition. |
| AU2013361106B2 (en) | 2012-12-21 | 2017-06-01 | Teikoku Pharma Usa, Inc. | Compositions and methods for transdermal delivery of hormones and other medicinal agents |
| US8697753B1 (en) | 2013-02-07 | 2014-04-15 | Polichem Sa | Method of treating onychomycosis |
| EP2952208A1 (en) * | 2014-06-04 | 2015-12-09 | Universidade de Santiago de Compostela | Hydroalcoholic system for nail treatment |
| CN118453831A (zh) | 2014-10-21 | 2024-08-09 | 戴夫生物技术私人有限公司 | 一种治疗方法 |
| KR101690765B1 (ko) * | 2015-04-17 | 2016-12-28 | 동아제약 주식회사 | 항진균성 활성물질을 포함하는 경피 제제 |
| GB201511799D0 (en) * | 2015-07-06 | 2015-08-19 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| EP3337471A4 (en) * | 2015-08-17 | 2019-04-10 | Ohio State Innovation Foundation | METHOD AND COMPOSITIONS FOR IMPROVED TRANSITIONAL DELIVERY OF AR-12 |
| US10272054B2 (en) * | 2015-10-07 | 2019-04-30 | Exodos Life Sciences Lp | Topical antifungal compositions |
| GB201605127D0 (en) * | 2016-03-25 | 2016-05-11 | Blueberry Therapeutics Ltd | Composition and methods of treatment |
| WO2017216722A2 (en) * | 2016-06-13 | 2017-12-21 | Vyome Biosciences Pvt. Ltd. | Synergistic antifungal compositions and methods thereof |
| KR20190037229A (ko) * | 2016-06-13 | 2019-04-05 | 바이옴 테라퓨틱스 리미티드 | 상승효과적 항진균 조성물 및 그의 방법 |
| IL287622B (en) | 2016-11-28 | 2022-07-01 | Cellix Bio Private Ltd | Preparations and methods for treating fungal infections |
| WO2019214838A1 (en) * | 2018-05-09 | 2019-11-14 | Eviderm Institute Ab | Use of an alcohol-containing composition for improving the skin barrier function |
| WO2019234546A1 (en) * | 2018-06-04 | 2019-12-12 | Zenvision Pharma Llp | Antifungal cuticle oil composition |
| EP3603650A1 (fr) | 2018-08-01 | 2020-02-05 | Edix O Sarl | Compositions injectables et a duree d'action prolongee pour leur utilisation dans le traitement de maladies de l'ongle et/ou pour accelerer la croissance de l'ongle |
| CN112888443A (zh) | 2018-08-01 | 2021-06-01 | 爱迪克斯-欧有限公司 | 用于其在治疗指或趾甲疾病中的使用和/或用于加速指或趾甲生长的具有延长的作用持续时间的可注射组合物 |
| EP3941985A4 (en) | 2019-03-19 | 2022-11-02 | Dow Global Technologies LLC | AQUEOUS DISPERSION WITH MULTISTAGE POLYMER PARTICLES |
| CN113208937A (zh) * | 2020-01-21 | 2021-08-06 | 中国医学科学院北京协和医院 | 一种角质软化组合物及其制备方法和应用及治疗灰指甲的外用复方及其制备方法和应用 |
| JP7664026B2 (ja) * | 2020-08-06 | 2025-04-17 | 沢井製薬株式会社 | エフィナコナゾール含有爪外用液 |
| JP2022117408A (ja) * | 2021-01-29 | 2022-08-10 | 花王株式会社 | 外用剤組成物 |
| CN113234028B (zh) * | 2021-04-29 | 2022-08-26 | 上海大学 | 一种5-氟尿嘧啶与肌氨酸的共晶体及其制备方法与用途 |
| CN113786382B (zh) * | 2021-11-04 | 2024-05-28 | 浙江得恩德制药股份有限公司 | 一种盐酸特比萘芬凝胶及制备方法 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7713618L (sv) | 1977-12-01 | 1979-06-02 | Astra Laekemedel Ab | Lokalanestetisk blandning |
| IT1180295B (it) | 1984-10-08 | 1987-09-23 | Durst Phototechnik Srl | Ingranditore o riproduttore fotografico a colori |
| FR2673537B1 (fr) | 1991-03-08 | 1993-06-11 | Oreal | Utilisation d'agents de penetration hydrophiles dans les compositions dermatologiques pour le traitement des onychomycoses, et compositions correspondantes. |
| CN1255850A (zh) | 1997-05-14 | 2000-06-07 | 盖伦(化学制品)有限公司 | 局部用组合物 |
| DE69918087D1 (de) * | 1998-04-17 | 2004-07-22 | Bertek Pharm Inc | Topische formulierungen zur behandlung von nagel pilzerkrankungen |
| US6368618B1 (en) | 1999-07-01 | 2002-04-09 | The University Of Georgia Research Foundation, Inc. | Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs |
| DE10035991A1 (de) * | 2000-07-24 | 2002-02-14 | Polichem Sa | Nagellackzusammensetzung |
| DE60223694T2 (de) | 2001-09-04 | 2008-10-30 | Trommsdorff Gmbh & Co. Kg Arzneimittel | Pflaster zur behandlung von funktionsstörungen und störungen des nagelwachstums |
| US20030091666A1 (en) * | 2001-11-14 | 2003-05-15 | Howard Murad | Methods and compositions for treating dermatological disorders with Morinda citrifolia |
| US7138394B2 (en) | 2002-09-27 | 2006-11-21 | Alpharx Inc. | Vehicle for topical delivery of anti-inflammatory compounds |
| HRP20050918A2 (en) * | 2003-03-21 | 2006-12-31 | Nexmed Holdings | Antifungal nail coat and method of use |
| CA2536482C (en) | 2003-08-25 | 2012-07-24 | Foamix Ltd. | Penetrating pharmaceutical foam |
| US20060078580A1 (en) * | 2004-10-08 | 2006-04-13 | Mediquest Therapeutics, Inc. | Organo-gel formulations for therapeutic applications |
| US20060078599A1 (en) | 2004-10-12 | 2006-04-13 | Mathew Ebmeier | Pharmaceutical composition applicable to body tissue |
| CA2500907A1 (en) | 2005-03-15 | 2006-09-15 | Alpharx Inc. | Vehicle for topical delivery of anti-inflammatory compounds |
| EP1858556A1 (en) | 2005-03-16 | 2007-11-28 | Alpharx Inc. | Vehicle for topical delivery of anti-inflammatory compounds |
| GB0511499D0 (en) * | 2005-06-06 | 2005-07-13 | Medpharm Ltd | Topical ungual formulations |
| US20070224261A1 (en) | 2006-03-22 | 2007-09-27 | Peter Draper | Eutectic liquid drug formulation |
| EP2457560A1 (en) | 2006-06-14 | 2012-05-30 | Dr Reddy's Laboratories Limited | Topical compositions |
| WO2008121709A1 (en) * | 2007-03-30 | 2008-10-09 | Transport Pharmaceuticals, Inc. | Pharmaceutical formulations for iontophoretic delivery of an anti-fungal drug |
| CA2731455A1 (en) | 2008-07-23 | 2010-01-28 | Gregor Cevc | Methods of administering topical antifungal formulations for the treatment of fungal infections |
| WO2011014850A2 (en) * | 2009-07-31 | 2011-02-03 | Nuvo Research Inc. | Topical eutectic-based formulations |
-
2010
- 2010-12-22 WO PCT/US2010/061940 patent/WO2011079234A2/en not_active Ceased
- 2010-12-22 AU AU2010336441A patent/AU2010336441B2/en not_active Ceased
- 2010-12-22 JP JP2012546222A patent/JP5829217B2/ja not_active Expired - Fee Related
- 2010-12-22 CN CN2010800643152A patent/CN102770123A/zh active Pending
- 2010-12-22 CA CA2785643A patent/CA2785643A1/en not_active Abandoned
- 2010-12-22 EP EP10801340A patent/EP2544659A2/en not_active Withdrawn
-
2012
- 2012-06-15 US US13/525,108 patent/US9084754B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2016508158A5 (enExample) | ||
| JP2011140525A5 (enExample) | ||
| WO2012085523A3 (en) | Skin sanitizer compositions comprising alcohol based emulsion | |
| WO2011079234A3 (en) | Highly permeating terbinafine formulation for treating onychomycosis | |
| JP2013534248A5 (enExample) | ||
| ECSP13012668A (es) | Ácidos 1-bencilcicloalquilcarboxílicos sustituidos y su uso | |
| SG10201400685SA (en) | Use Of Eicosapentaenoic Acid Ethyl Ester For Treating Hypertriglyceridemia | |
| JP2011116787A5 (enExample) | ||
| WO2014067986A8 (en) | Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosis | |
| CR20120605A (es) | Formulación tópica para un inhibidor de jak | |
| MX2011011614A (es) | Acidos grasos poliinsaturados para el tratamiento de trastornos relacionados a las areas de los trastornos cardiovasculares, metabolicos e inflamatorios. | |
| HK1198921A1 (en) | Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof | |
| WO2010101742A3 (en) | Ampholytic ter-polymers for use in personal care compositions | |
| PH12013500923A1 (en) | Compositions of rotigotine, derivatives thereof, or pharmaceutically acceptable salts of rotigotine or its derivative | |
| BR112012019374A2 (pt) | composição farmacêutica, pellet de liberação prolongada, composição farmacêutica oral, método para tratamento de uma doença neurodegenerativa ou um dano ao sistema nervoso em um indivíduo necessitado do mesmo e método para preparação de uma formulação de liberação prolongada de um agente ativo | |
| NZ592647A (en) | Pharmaceutical formulation comprising diclofenac and a hydroxy fatty acid polyoxyalkylene ester | |
| RU2009101326A (ru) | Препарат для наружного применения на кожу, содержащий тритерпеновую кислоту | |
| NZ596228A (en) | Compositions and methods for the treatment of inflammation | |
| EP2827868A4 (en) | PHARMACEUTICAL COMPOSITIONS WITH FATTY ACID ESTERS | |
| JP2014218522A5 (enExample) | ||
| ME02147B (me) | Jedinjenje sa topikalnom primjenom za aktinične keratoze | |
| TW201129396A (en) | Topical formulation | |
| CR20140053A (es) | Formulaciones de ácido desoxicólico y sales del mismo | |
| BR112013000613A2 (pt) | composições secas e dispositivos que contêm tais composições secas | |
| AU2015275248B2 (en) | Legumain activated doxorubicin derivative as well as preparation method and application thereof |